KPTI (Karyopharm Therapeutics Inc) may reap gains as insiders became active recently

Karyopharm Therapeutics Inc’s filing revealed that its President and CEO Paulson Richard A. unloaded Company’s shares for reported $1680.0 on May 06 ’25. In the deal valued at $7.12 per share,236 shares were sold. As a result of this transaction, Paulson Richard A. now holds 82,503 shares worth roughly $0.38 million.

Then, Rangwala Reshma sold 419 shares, generating $2,585 in total proceeds. Upon selling the shares at $6.17, the EVP & Chief Medical Officer now owns 28,853 shares.

Before that, Paulson Richard A. sold 245 shares. Karyopharm Therapeutics Inc shares valued at $916 were divested by the President and CEO at a price of $3.74 per share. As a result of the transaction, Paulson Richard A. now holds 82,739 shares, worth roughly $0.38 million.

A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. RBC Capital Mkts also remained covering KPTI and has increased its forecast on November 04, 2022 with a “an Outperform” recommendation from previously “Sector perform” rating. JP Morgan revised its rating on February 09, 2022. It rated KPTI as “a Neutral” which previously was an “an Underweight”.

Price Performance Review of KPTI

On Friday, Karyopharm Therapeutics Inc [NASDAQ:KPTI] saw its stock fall -9.00% to $4.55. Over the last five days, the stock has gained 3.64%. Karyopharm Therapeutics Inc shares have fallen nearly -64.04% since the year began. Nevertheless, the stocks have fallen -55.15% over the past one year. While a 52-week high of $16.95 was reached on 01/06/25, a 52-week low of $3.51 was recorded on 04/01/25.

Levels Of Support And Resistance For KPTI Stock

The 24-hour chart illustrates a support level at 3.97, which if violated will result in even more drops to 3.39. On the upside, there is a resistance level at 4.85. A further resistance level may holdings at 5.16.

How much short interest is there in Karyopharm Therapeutics Inc?

A steep rise in short interest was recorded in Karyopharm Therapeutics Inc stocks on 2025-06-13, dropping by 66364.0 shares to a total of 2.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.09 million shares. There was a decline of -3.28%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.